June 8, 2021 —Johnson & Johnson Innovation, together with Neutrogena®, announced today that EADEM has been selected as the awardee in Black Innovators in Skin Health QuickFire Challenge. The challenge offered an opportunity for U.S.-based Black innovators working on potential skin health solutions to receive grant funding and mentorship from experts across the Johnson & Johnson Family of Companies to help advance their science.
EADEM is a clean beauty brand centered around women of color and their beauty needs for bare-skin confidence. Pioneering Smart Melanin Beauty, EADEM aims to offer skincare uniquely formulated for skin of color.
To help advance their research, EADEM will receive $50,000 in grant funding, mentoring from experts across the Johnson & Johnson Family of Companies, and access to the Johnson & Johnson Innovation - JLABS ecosystem.
The QuickFire Challenges are managed by Johnson & Johnson Innovation with the goal to help address today’s greatest health care challenges.
NEUTROGENA®, the #1 dermatologist recommended skincare brand, has brought groundbreaking skincare solutions to consumers for more than 60 years. Today the brand offers more than 650 products worldwide in the face, body, acne, sun protection, makeup, men’s care, and anti-wrinkle categories. By creating, innovating and rethinking what is possible, NEUTROGENA® products consistently deliver real results without compromises.
About Johnson & Johnson Innovation
Johnson & Johnson Innovation, LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation—JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com.
About Johnson & Johnson Innovation—JLABS
Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jlabs.jnjinnovation.com or follow @JLABS.